2-4-(2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)-1- piperidinyl or 1,2,3,6-tetrahydro-1- pyridinyl))alkyl-1h-benzdeisoquinoline-1, 3(2h)-diones
CA 1088540 A · Owner: E. R. Squibb & Sons, Inc. · Inventors: Vogt, Berthold R.; Wade, Peter C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
New compounds which exhibit antidepressant activity and are also useful as antiinflammatory agents have, the following formula, wherein R1 and R2 are independently selected from hydrogen halogen, lower alkyl, lower alkoxy, lower alkylthio nitro, amino, trifluoromethyl and cyano: R3 is hydrogen or lower alky; R4 and R5 are independently selected from hydrogen lower alkyl, lower alkoxy and halogen; A is straight or branched chain alkylene of 1 to 8 carbons; the dashed line indicates the optional presence of a double bond; and a pharmaceutically acceptable acid addition salt thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 28, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 28, 1997.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.